Table 4.
Country distribution for COVID-19 vaccine citations.
| Intergovernmental organization status and region | Value, n (%) | |||
| Intergovernmental organizations included (n=1900) |
|
|||
|
|
United States and Europe | 1811 (95.3) | ||
|
|
|
Switzerland | 1285 (67.6) | |
|
|
|
Netherlands | 190 (10.0) | |
|
|
|
United States | 161 (8.5) | |
|
|
|
United Kingdom | 97 (5.1) | |
|
|
|
Italy | 51 (2.7) | |
|
|
|
France | 10 (0.5) | |
|
|
|
Norway | 8 (0.4) | |
|
|
|
Germany | 5 (0.3) | |
|
|
|
Brussel | 2 (0.1) | |
|
|
|
Spain | 2 (0.1) | |
|
|
Others | 89 (4.7) | ||
|
|
|
Australia | 57 (3.0) | |
|
|
|
Ethiopia | 18 (0.9) | |
|
|
|
South Africa | 8 (0.4) | |
|
|
|
India | 4 (0.2) | |
|
|
|
Panama | 2 (0.1) | |
| Intergovernmental organizations excluded (n=447) |
|
|||
|
|
Netherlands | 145 (32.4) | ||
|
|
United States | 98 (21.9) | ||
|
|
United Kingdom | 97 (21.7) | ||
|
|
Australia | 57 (12.8) | ||
|
|
Italy | 18 (4.0) | ||
|
|
Norway | 8 (1.8) | ||
|
|
South Africa | 8 (1.8) | ||
|
|
Germany | 5 (1.1) | ||
|
|
India | 4 (0.9) | ||
|
|
Panama | 2 (0.4) | ||
|
|
Belgium | 2 (0.4) | ||
|
|
Spain | 2 (0.4) | ||
|
|
Switzerland | 1 (0.2) | ||